ES3052874T3 - Composition comprising sodium hyaluronate and amino acids for use in the orthopedic field - Google Patents

Composition comprising sodium hyaluronate and amino acids for use in the orthopedic field

Info

Publication number
ES3052874T3
ES3052874T3 ES22789675T ES22789675T ES3052874T3 ES 3052874 T3 ES3052874 T3 ES 3052874T3 ES 22789675 T ES22789675 T ES 22789675T ES 22789675 T ES22789675 T ES 22789675T ES 3052874 T3 ES3052874 T3 ES 3052874T3
Authority
ES
Spain
Prior art keywords
concentration
composition according
sodium hyaluronate
molecular weight
kda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES22789675T
Other languages
English (en)
Spanish (es)
Inventor
Edoardo Conti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROFESSIONAL DERMA SA
Original Assignee
PROFESSIONAL DERMA SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROFESSIONAL DERMA SA filed Critical PROFESSIONAL DERMA SA
Application granted granted Critical
Publication of ES3052874T3 publication Critical patent/ES3052874T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
ES22789675T 2021-09-16 2022-09-15 Composition comprising sodium hyaluronate and amino acids for use in the orthopedic field Active ES3052874T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102021000023894A IT202100023894A1 (it) 2021-09-16 2021-09-16 Composizione per utilizzo in campo ortopedico
PCT/IB2022/058720 WO2023042120A1 (en) 2021-09-16 2022-09-15 Composition comprising sodium hyaluronate and am inoacids for use in the orthopedic filed

Publications (1)

Publication Number Publication Date
ES3052874T3 true ES3052874T3 (en) 2026-01-15

Family

ID=78771031

Family Applications (1)

Application Number Title Priority Date Filing Date
ES22789675T Active ES3052874T3 (en) 2021-09-16 2022-09-15 Composition comprising sodium hyaluronate and amino acids for use in the orthopedic field

Country Status (11)

Country Link
US (1) US20240366653A1 (pl)
EP (1) EP4401743B1 (pl)
KR (1) KR20240063914A (pl)
CN (1) CN117957004A (pl)
AU (1) AU2022345524A1 (pl)
ES (1) ES3052874T3 (pl)
HR (1) HRP20251328T1 (pl)
IT (1) IT202100023894A1 (pl)
PL (1) PL4401743T3 (pl)
RS (1) RS67349B1 (pl)
WO (1) WO2023042120A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU505892B1 (fr) * 2023-12-21 2025-06-24 Lumatrix Formule pharmaceutique de cicatrisation et de régénération de la peau et son utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052515A1 (it) * 2005-12-29 2007-06-30 Abiogen Pharma Spa Formulazione farmaceutica per il trattamento della osteoartrite
CA2910325A1 (en) * 2013-04-25 2014-10-30 Aluron Biopharma Inc. Crosslinked hyaluronic acid compositions

Also Published As

Publication number Publication date
AU2022345524A1 (en) 2024-02-15
HRP20251328T1 (hr) 2025-12-19
IT202100023894A1 (it) 2023-03-16
EP4401743B1 (en) 2025-09-03
CN117957004A (zh) 2024-04-30
PL4401743T3 (pl) 2025-12-15
RS67349B1 (sr) 2025-11-28
EP4401743C0 (en) 2025-09-03
WO2023042120A1 (en) 2023-03-23
KR20240063914A (ko) 2024-05-10
US20240366653A1 (en) 2024-11-07
EP4401743A1 (en) 2024-07-24

Similar Documents

Publication Publication Date Title
Marzook et al. Intra-articular injection of a mixture of hyaluronic acid and corticosteroid versus arthrocentesis in TMJ internal derangement
Van Valburg et al. Joint distraction in treatment of osteoarthritis: a two-year follow-up of the ankle
EA011708B1 (ru) Применение транс- капсаицина
JP2011105741A (ja) 骨関節症を治療するための、ヒアルロン酸ナトリウムとコンドロイチン硫酸との混合物の使用
ES2317018T3 (es) Procedimiento para el tratamiento de un esguince y una distension agudos o debidos a una utilizacion excesiva utilizando acido hialuronico.
Petrella et al. Long-term efficacy and safety of periarticular hyaluronic acid in acute ankle sprain
Razzano et al. Noninvasive interactive neurostimulation therapy for the treatment of low-grade lateral ankle sprain in the professional contact sport athlete improves the short-term recovery and return to sport: a randomized controlled trial
ES3052874T3 (en) Composition comprising sodium hyaluronate and amino acids for use in the orthopedic field
RU2268052C2 (ru) Средство для лечения воспалительных и дегенеративных заболеваний суставов (варианты), способ лечения воспалительных и дегенеративных заболеваний суставов (варианты) и устройство для доставки лекарственного средства к пораженному участку
US20160106774A1 (en) Liquid pharmaceutical composition containing piroxicam and hyaluronic acid for the treatment of osteoarthritis
KR20220152904A (ko) Dna 분획물 및 콘드로이틴 설페이트를 포함하는 관절염 예방 또는 치료용 조성물
ES2447829T3 (es) Combinación para el tratamiento de la osteoartritis
Yu et al. Creatine derivatives: rapid complete relief of pain by topical or transcutaneous administration
CN110711244B (zh) 一种神经导向因子Sema在制备治疗骨关节炎搽剂中的应用
HK40109892A (zh) 用於整形外科领域的包含透明质酸钠和氨基酸的组合物
Dohnert et al. High frequency transcutaneous electrical stimulation in the immediate postoperative period of anterior cruciate ligament reconstruction: a randomized clinical trial
RU2350366C1 (ru) Способ лечения последствий травм суставов
Lynen Treatment of chronic tendinopathies with peritendinous hyaluronan injections under sonographic guidance—An interventional, prospective, single-arm, multicenter study
US11642328B2 (en) Creatine, its derivatives, compositions and methods of use thereof
EP3687550A1 (en) New therapy for osteoarthritic pain
US11654185B2 (en) Use of hyaluronidase for treatment of muscle stiffness
Dohnert et al. Received: Feb 04, 2021 Revised: Apr 21, 2021 Approved: Jun 05, 2021
WO2022157181A1 (en) Use of link-tsg6 for the treatment of osteoarthritic pain
Milani The collagen Medical Devices in the local treatment of the algic arthro-rheumopathies
RU2436584C1 (ru) Способ лечения дегеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических спаечных процессов